• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Vital Signs in Pregnancy: Defining Normal Ranges

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Data defining normal ranges for maternal vital signs in pregnancy are limited
    • Data required to develop better early warning tools
  • Green et al. (Obstetrics & Gynecology, 2020) determined physiologic vital sign measurements using standardized techniques throughout pregnancy

METHODS:

  • Three-center, prospective, longitudinal cohort study
  • Setting
    • The United Kingdom (2012 to 2017)
  • Participants
    • <20 weeks | Accurately dated | Singleton pregnancies | No significant comorbidities or complications
  • Study design
    • Measurements every 4 to 6 weeks  
    • Vitals
      • BP
      • Heart rate
      • Respiratory rate
      • Oxygen saturation
      • Temperature

RESULTS:

  • 1,041 women
  • Systolic and diastolic BP decreased slightly from 12 weeks of gestation to 18.6 to 19.2 weeks
    • Median (3rd to 97th centile) at 12 weeks
      • Systolic: 114 (95 to 138) mm Hg
      • Diastolic: 70 (56 to 87) mm Hg
    • Minimum BP
      • Systolic at 18.6 weeks: 113 (95 to 136) mm Hg
      • Diastolic at 19.2 weeks: 69 (55 to 86) mm Hg
    • A change (95% CI) of
      • Systolic: −1.0 (−2 to 0) mm Hg
      • Diastolic: −1 (−2 to −1) mm Hg
  • Systolic and diastolic BP then both rose to a maximum median at 40 weeks’ gestation
    • Maximum median (3rd to 97th centile)
      • Systolic: 121 (102 to 144) mm Hg
      • Diastolic: 78 (62 to 95) mm Hg
    • A change (95% CI) of
      • Systolic: 7 (6 to 9) mm Hg
      • Diastolic: 9 (8 to 10) mm Hg
  • Median heart rate
    • Lowest at 12 weeks’ gestation with a maximum at 34.1 weeks
    • Median (3rd to 97th centile) at 12 weeks’
      • 82 (63 to 105) bpm
    • Maximum median (3rd to 97th centile) at 34.1 weeks
      • 91 (68 to 115) bpm
  • SpO2
    • Decreased from 12 weeks’ gestation to 40 weeks’ gestation
    • Median (3rd to 97th centile) at 12 weeks
      • 98% (94 to 99%)
    • Median at 40 weeks
      • 97% (93 to 99%)
  • Respiratory rate
    • Median respiratory rate at 12 weeks of gestation did not change with gestation
    • Median (3rd to 97th centile) at 12 weeks
      • 15 (9 to 22)
  • Temperature
    • Median temperature at 12 weeks decreased to a minimum at 33.4 weeks
    • Median (3rd to 97th centile) at 12 weeks
      • 36.7 (35.6 to 37.5) °C
    • Median at 33.4 weeks
      • 36.5 (35.3 to 37.3) °C

CONCLUSION:

  • Gestational age specific centile ranges can be used to identify women who are at risk for pregnancy complications
  • The authors note that their data can set appropriate thresholds
    • SpO2 of 94% is still within the normal range
    • Heart of 115 was to upper limit of normal and waiting till HR of 120 may be too high a threshold for a maternal warning alert
    • The classic 10 to 15 mm Hg BP drop was not seen in this study and therefore using <90 mm Hg  systolic as a trigger for sepsis may too low

Learn More – Primary Sources:

Gestation-Specific Vital Sign Reference Ranges in Pregnancy

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst®

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Pregnancy-Related Deaths in the U.S.: How Many are Preventable?
Is Maternal Core Temperature Elevated Beyond a Critical Threshold During Exercise in Pregnancy?
New ACC Blood Pressure Guidelines in Pregnancy: Should We Start Monitoring Prior to 140/90?
SMFM & CMQCC Guidelines: Making the Diagnosis of Sepsis in Pregnancy

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site